UK Response to COVID-19 Pandemic Shows World-Leading Life Sciences Innovation

To say it has been quite an 18 months is an understatement. The life sciences industry was hit hard in parts, with a pausing of clinical trials, investment in start-ups and prioritisation on COVID-19 treatments.